Target | cis/trans | Study | SNP | SNP location | Maj/min allele | MAF | N | βinv | seinv | Pinv | fclog | Plog | Praw |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MICB | cis | Discovery | rs2284178 | 6:31,432,125 | C/T | 0.47 | 993 | 0.344 | 0.044 | 1.1×10-14 | 1.130 | 1.9×10-8 | 0.007 |
MICB | cis | Replication | rs2284178 | 6:31,432,125 | A/G | 0.47 | 337 | -0.267 | 0.060 | 1.2×10-5 | -1.130 | 1.5×10-5 | 0.015 |
Target (abbrv.) | MICB |
Target (full name) | MHC class I polypeptide-related sequence B |
Somalogic ID (Sequence ID) | SL005200 (5102-55_3) |
Entrez Gene Symbol | MICB |
UniProt ID | Q29980 |
UniProt Comment |
|
Biomarker applications (based on IPA annotation) |
|
Pathway Studio |
|
All locus annotations are based on the sentinel SNP (rs2284178) and 1 proxy variant(s) that is/are in linkage disequilibrium r2 ≥ 0.8. Linkage disequilibrium is based on data from the 1000 Genomes Project, phase 3 version 5, European population and was retrieved using SNiPA's Block Annotation feature.
Download the detailed results of SNiPA's block annotation (PDF)
Genes hit or close-by |
|
Potentially regulated genes | |
eQTL genes |
|
Trait | P | Study | Source |
---|---|---|---|
HIV-1 control | 4.6×10-28 | 21051598 (PMID) | GRASP2 nonQTL |
Type 1 diabetes | 1×10-16 | 17632545 (PMID) | GRASP2 nonQTL |
Methylation levels at chr6:31538845-31538895 [hg18 coord, probe cg13784557] in Frontal cortex | 2.5×10-12 | 20485568 (PMID) | GRASP2 meQTL |
Methylation levels at chr6:31538845-31538895 [hg18 coord, probe cg13784557] in Temporal cortex | 4.1×10-12 | 20485568 (PMID) | GRASP2 meQTL |
HIV-1 control (viral load at set point) | 5×10-12 | 20041166 (PMID) | GRASP2 nonQTL |
Methylation levels at chr6:31538845-31538895 [hg18 coord, probe cg13784557] in Caudal pons | 2.7×10-11 | 20485568 (PMID) | GRASP2 meQTL |
Idiopathic membranous nephropathy | 3.4×10-11 | 21323541 (PMID) | GRASP2 nonQTL |
Behcet syndrome | 3.1×10-10 | pha002888 (dbGaP) | dbGaP via SNiPA |
Gene expression of HLA-DRB4 [probe 215666_at] in lymphoblastoid cell lines | 1.4×10-9 | 17873877 (PMID) | GRASP2 eQTL |
Triglycerides | 3.7×10-8 | 24097068 (PMID) | Supplemental file |
Gene expression of CCHCR1 [probe 209698_at] in lymphoblastoid cell lines | 4.7×10-8 | 17873877 (PMID) | GRASP2 eQTL |
Gene expression of HLA-C in CEU lymphoblastoid cell lines | 1.9×10-7 | 17873874 (PMID) | GRASP2 eQTL |
HIV-1 seropositive nonprogression | 4.2×10-7 | 19115949 (PMID) | GRASP2 nonQTL |
Bipolar disorder vs. Schizophrenia | 5.3×10-7 | 24280982 (PMID) | Supplemental file |
HIV-1 control (viral load) | 6.3×10-7 | 21490045 (PMID) | GRASP2 nonQTL |
Schizophrenia | 1.5×10-6 | 25056061 (PMID) | Supplemental file |
Height | 5×10-6 | 25282103 (PMID) | Supplemental file |
Total cholesterol | 5.7×10-6 | 20686565 (PMID) | GRASP2 nonQTL |
HIV-1-specific cross-reactive neutralizing activity | 1.3×10-5 | 23372753 (PMID) | GRASP2 nonQTL |
Gene expression of ATP6V1G2///BAT1 in blood | 4.5×10-5 | 21829388 (PMID) | GRASP2 eQTL |
Cross-disorder, subset Schizophrenia | 1.1×10-4 | 23453885 (PMID) | Supplemental file |
Gene expression of LST1 [probe ILMN_22195] in osteoblasts treated with PGE2 | 2.5×10-4 | 21283786 (PMID) | GRASP2 eQTL |
HDL cholesterol | 4.4×10-4 | 24097068 (PMID) | Supplemental file |